scholarly journals Vorinostat and bortezomib as third-line therapy in patients with advanced non-small cell lung cancer: a Wisconsin Oncology Network Phase II study

2013 ◽  
Vol 32 (1) ◽  
pp. 195-199 ◽  
Author(s):  
Tien Hoang ◽  
Toby C. Campbell ◽  
Chong Zhang ◽  
KyungMann Kim ◽  
Jill M. Kolesar ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Line Therapy ◽  
Third Line Therapy ◽  
Third Line

scholarly journals Phase II Study of Docetaxel in Combination with Everolimus for Second- or Third-Line Therapy of Advanced Non–Small-Cell Lung Cancer

2013 ◽  
Vol 8 (3) ◽  
pp. 369-372 ◽  
Author(s):  
Suresh S. Ramalingam ◽  
Taofeek K. Owonikoko ◽  
Madhusmita Behera ◽  
Janakiraman Subramanian ◽  
Nabil F. Saba ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Line Therapy ◽  
Third Line Therapy ◽  
Third Line

scholarly journals Everolimus and Erlotinib as Second- or Third-Line Therapy in Patients with Advanced Non–Small-Cell Lung Cancer

2012 ◽  
Vol 7 (10) ◽  
pp. 1594-1601 ◽  
Author(s):  
Vassiliki A. Papadimitrakopoulou ◽  
Jean-Charles Soria ◽  
Annette Jappe ◽  
Valentine Jehl ◽  
Judith Klimovsky ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Line Therapy ◽  
Third Line Therapy ◽  
Third Line

Phase II Study of Irinotecan Plus Cisplatin as First Line therapy in Extensive Small-Cell Lung Cancer

2006 ◽  
Vol 61 (2) ◽  
pp. 143
Author(s):  
Ki Eun Hwang ◽  
So Young Kim ◽  
Jong Hoon Jung ◽  
Seong Hoon Park ◽  
Jung Hyun Park ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

Weekly docetaxel as II line therapy in non-small cell lung cancer: an interim analysis of a phase II study

Lung Cancer ◽  
2001 ◽  
Vol 34 ◽  
pp. 31-35 ◽  
Author(s):  
Maria Rosaria Valerio ◽  
Antonio Russo ◽  
Mario Adelfio Latteri ◽  
Giuseppe Modica ◽  
Gaspare Gulotta ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Interim Analysis ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Weekly Docetaxel ◽  
Line Therapy

Phase II study of weekly plitidepsin as second-line therapy for small cell lung cancer

Lung Cancer ◽  
2009 ◽  
Vol 64 (1) ◽  
pp. 60-65 ◽  
Author(s):  
Tim Eisen ◽  
Nick Thatcher ◽  
Serge Leyvraz ◽  
Wilson H. Miller ◽  
Felix Couture ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Second Line ◽  
Small Cell Lung ◽  
Second Line Therapy ◽  
Line Therapy

scholarly journals P3.02b-065 Third Line Therapy in EGFR Positive Advanced Non-Small Cell Lung Cancer

2017 ◽  
Vol 12 (1) ◽  
pp. S1229-S1230
Author(s):  
Nikhil Pande ◽  
Amit Joshi ◽  
Vanita Noronha ◽  
Vijay Patil ◽  
Anuradha Chougule ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Line Therapy ◽  
Third Line Therapy ◽  
Third Line

Clinical predictive factors for advanced non-small cell lung cancer (NSCLC) patients receiving third-line therapy: Selecting the unselectable?

Lung Cancer ◽  
2010 ◽  
Vol 68 (3) ◽  
pp. 433-437 ◽  
Author(s):  
Mario Scartozzi ◽  
Paola Mazzanti ◽  
Riccardo Giampieri ◽  
Rossana Berardi ◽  
Eva Galizia ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Predictive Factors ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Line Therapy ◽  
Third Line Therapy ◽  
Third Line ◽  
Nsclc Patients
Sign in / Sign up

Export Citation Format

Share Document